Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta‐analysis
Background Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational inte...
Saved in:
Published in | Helicobacter (Cambridge, Mass.) Vol. 27; no. 2; pp. e12880 - n/a |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.04.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta‐analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori.
Materials and Methods
We searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random‐effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses.
Results
Our search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04–1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14–1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05).
Conclusions
Patient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens. |
---|---|
AbstractList | Background
Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta‐analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori.
Materials and Methods
We searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random‐effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses.
Results
Our search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04–1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14–1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05).
Conclusions
Patient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens. Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta-analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori. We searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random-effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses. Our search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04-1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14-1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05). Patient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens. Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta-analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori.BACKGROUNDHelicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta-analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori.We searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random-effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses.MATERIALS AND METHODSWe searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random-effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses.Our search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04-1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14-1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05).RESULTSOur search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04-1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14-1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05).Patient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens.CONCLUSIONSPatient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens. BackgroundHelicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta‐analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori.Materials and MethodsWe searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random‐effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses.ResultsOur search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04–1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14–1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05).ConclusionsPatient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens. |
Author | Zuo, Xiuli Li, Yue‐yue Han, Zhong‐xue Qu, Jun‐yan Yang, Xiao‐xiao Zha, Jing |
Author_xml | – sequence: 1 givenname: Jing surname: Zha fullname: Zha, Jing organization: Shandong University – sequence: 2 givenname: Yue‐yue surname: Li fullname: Li, Yue‐yue organization: Shandong University – sequence: 3 givenname: Jun‐yan surname: Qu fullname: Qu, Jun‐yan organization: Shandong University – sequence: 4 givenname: Xiao‐xiao surname: Yang fullname: Yang, Xiao‐xiao organization: Shandong University – sequence: 5 givenname: Zhong‐xue surname: Han fullname: Han, Zhong‐xue organization: Shandong University – sequence: 6 givenname: Xiuli orcidid: 0000-0001-9556-8771 surname: Zuo fullname: Zuo, Xiuli email: zuoxiuli@sdu.edu.cn organization: Shandong University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35150600$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU2OEzEQhS00iPmBBRdAltjAomf8E3e72Y1GgSBFYgNry-2UFY_cdrDdRM2KI3BGToIzyWxGUJsqyd97Kte7RGchBkDoNSXXtNbNFvw1ZVKSZ-iCCsYbwTt5VmciebPgsj9HlznfE0IEX_Qv0DkXVJCWkAv0c2ktmJJxtBjCVgcDGwybyejiYsA2JryrI4SK7F3Z4rIFvALvTBy0KVCfZx-Twy4cfKrmA77Fec4FxqozOMEPB3uswwaPUPSfX7910H7OLr9Ez632GV6d-hX69nH59W7VrL98-nx3u24Mr19q-sXAW61NZ7k1tKUMhg6E7RhwIAZa01NYGEMG4ESwjgPTA-mZBW1lK5jgV-jd0XeX4vcJclGjywa81wHilBVrmWR939ED-vYJeh-nVPc9ULwTUraMVerNiZqGETZql9yo06wer1qBmyNgUsw5gVXGlYeDlqSdV5SoQ26q5qYecquK908Uj6b_Yk_ue-dh_j-oVsv1UfEXWgao8Q |
CitedBy_id | crossref_primary_10_1111_hel_13115 crossref_primary_10_1111_hel_13137 crossref_primary_10_1111_hel_13114 crossref_primary_10_1155_2022_4710964 crossref_primary_10_3390_antibiotics11121746 crossref_primary_10_4081_ijfs_2024_12176 crossref_primary_10_3389_fpubh_2023_1344212 crossref_primary_10_1111_hel_13078 crossref_primary_10_1111_hel_13055 crossref_primary_10_1177_17562848241258021 crossref_primary_10_3390_antibiotics13100965 crossref_primary_10_1002_ddr_22025 crossref_primary_10_1111_hel_12912 crossref_primary_10_1111_jgh_16348 crossref_primary_10_1111_hel_12938 crossref_primary_10_2147_JMDH_S419630 crossref_primary_10_1111_hel_13102 crossref_primary_10_3390_antibiotics12020191 crossref_primary_10_1111_hel_13048 crossref_primary_10_3389_fcimb_2022_1049279 crossref_primary_10_1136_gutjnl_2024_332640 crossref_primary_10_33003_fjs_2024_0806_2845 crossref_primary_10_1136_gutjnl_2021_325948 crossref_primary_10_3390_antibiotics12020346 crossref_primary_10_1111_hel_12989 crossref_primary_10_1186_s13099_023_00556_x crossref_primary_10_3390_diagnostics13111918 |
Cites_doi | 10.1001/jama.2012.3507 10.1136/gutjnl-2016-312288 10.11613/BM.2012.031 10.1186/s12929-018-0469-6 10.1016/0016-5085(92)90095-G 10.1056/NEJMra050100 10.1016/j.amjmed.2016.06.011 10.1259/bjr.20190389 10.1111/apt.12516 10.1111/apt.13497 10.1080/00332747.2016.1237753 10.1046/j.0306-5251.2001.01531.x 10.1016/j.canlet.2013.08.016 10.1111/j.1365-2036.2011.04887.x 10.1111/j.1572-0241.1999.00856.x 10.3748/wjg.v21.i39.11179 10.1155/2020/8972473 10.1111/jgh.15468 10.1136/bmj.315.7109.629 10.1053/j.gastro.2021.10.048 10.1177/1756283X09337342 10.1111/apt.14561 10.1080/00365521.2017.1413132 10.1053/j.gastro.2019.04.011 10.1080/0142159X.2019.1595557 10.2165/00003495-199754060-00002 10.1111/hel.12569 10.1053/j.gastro.2017.04.022 10.2307/2533446 10.1111/hel.12682 10.1111/hel.12832 10.1016/j.jclinepi.2009.06.005 10.1136/bmj.d5928 10.1111/hel.12475 |
ContentType | Journal Article |
Copyright | 2022 John Wiley & Sons Ltd 2022 John Wiley & Sons Ltd. Copyright © 2022 John Wiley & Sons Ltd |
Copyright_xml | – notice: 2022 John Wiley & Sons Ltd – notice: 2022 John Wiley & Sons Ltd. – notice: Copyright © 2022 John Wiley & Sons Ltd |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL C1K K9. 7X8 |
DOI | 10.1111/hel.12880 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology Education |
EISSN | 1523-5378 |
EndPage | n/a |
ExternalDocumentID | 35150600 10_1111_hel_12880 HEL12880 |
Genre | reviewArticle Meta-Analysis Systematic Review Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China – fundername: Taishan Scholars Program of Shandong Province and National Clinical Research Center for Digestive Diseases supporting technology project |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29I 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EAD EAP EBC EBD EBS EDH EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OBS OIG OVD P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QL C1K K9. 7X8 |
ID | FETCH-LOGICAL-c3880-94b36aac7f3fc1612eb7e5f72e3e0ce6c91e4cc0be305273e2ab092feaf865253 |
IEDL.DBID | DR2 |
ISSN | 1083-4389 1523-5378 |
IngestDate | Fri Jul 11 09:18:23 EDT 2025 Fri Jul 25 10:36:09 EDT 2025 Mon Jul 21 06:06:26 EDT 2025 Tue Jul 01 00:54:47 EDT 2025 Thu Apr 24 23:10:50 EDT 2025 Wed Jan 22 16:26:48 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | meta-analysis enhanced patient education Helicobacter pylori systematic review eradication rate |
Language | English |
License | 2022 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3880-94b36aac7f3fc1612eb7e5f72e3e0ce6c91e4cc0be305273e2ab092feaf865253 |
Notes | Funding information This study was supported by the National Natural Science Foundation of China (82070551 and 81770538), the Taishan Scholars Program of Shandong Province, and the National Clinical Research Center for Digestive Diseases supporting technology project (2015BAI13B07) ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
ORCID | 0000-0001-9556-8771 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hel.12880 |
PMID | 35150600 |
PQID | 2637588622 |
PQPubID | 2034141 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2628299715 proquest_journals_2637588622 pubmed_primary_35150600 crossref_citationtrail_10_1111_hel_12880 crossref_primary_10_1111_hel_12880 wiley_primary_10_1111_hel_12880_HEL12880 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2022 2022-04-00 2022-Apr 20220401 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: April 2022 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Helicobacter (Cambridge, Mass.) |
PublicationTitleAlternate | Helicobacter |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2021; 26 1997; 315 2009; 62 2019; 92 2002; 53 2005; 353 2016; 129 2017; 66 1992; 102 2011; 34 2017; 153 2018; 23 2016; 79 2018; 25 2018; 47 2012; 307 2014; 86 2021; 36 2022; 162 2020; 2020 2013; 38 1997; 54 2019; 41 2019; 24 2015; 21 2016; 43 2019; 157 2020; 25 1999; 94 2009; 2 1994; 50 2012; 22 2018; 53 2014; 345 2011; 343 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 Osipenko MF (e_1_2_8_14_1) 2014; 86 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
References_xml | – volume: 66 start-page: 6 issue: 1 year: 2017 end-page: 30 article-title: Management of infection‐the Maastricht V/Florence Consensus Report publication-title: Gut – volume: 157 start-page: 44 issue: 1 year: 2019 end-page: 53 article-title: Reconciliation of recent treatment guidelines in a time of increasing resistance to antibiotics publication-title: Gastroenterology – volume: 50 start-page: 1088 issue: 4 year: 1994 end-page: 1101 article-title: Operating characteristics of a rank correlation test for publication bias publication-title: Biometrics – volume: 25 start-page: 65 issue: 1 year: 2018 article-title: pylori infection and extra‐gastroduodenal diseases publication-title: J Biomed Sci – volume: 315 start-page: 629 issue: 7109 year: 1997 end-page: 634 article-title: Bias in meta‐analysis detected by a simple, graphical test publication-title: BMJ (Clinical Research ed) – volume: 24 issue: 3 year: 2019 article-title: Twice daily short‐message‐based re‐education could improve eradication rate in young population: a prospective randomized controlled study publication-title: Helicobacter – volume: 47 start-page: 868 issue: 7 year: 2018 end-page: 876 article-title: Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection publication-title: Aliment Pharmacol Ther – volume: 92 issue: 1103 year: 2019 article-title: Artificial intelligence for precision education in radiology publication-title: Br J Radiol – volume: 53 start-page: 130 issue: 2 year: 2018 end-page: 133 article-title: Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study publication-title: Scand J Gastroenterol – volume: 307 start-page: 1959 issue: 18 year: 2012 end-page: 1969 article-title: Probiotics for the prevention and treatment of antibiotic‐associated diarrhea: a systematic review and meta‐analysis publication-title: JAMA – volume: 62 start-page: 1006 issue: 10 year: 2009 end-page: 1012 article-title: Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement publication-title: J Clin Epidemiol – volume: 34 start-page: 1255 issue: 11–12 year: 2011 end-page: 1268 article-title: Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough publication-title: Aliment Pharmacol Ther – volume: 54 start-page: 797 issue: 6 year: 1997 end-page: 800 article-title: Issues in patient compliance publication-title: Drugs – volume: 22 start-page: 276 issue: 3 year: 2012 end-page: 282 article-title: Interrater reliability: the kappa statistic publication-title: Biochem Med (Zagreb) – volume: 353 start-page: 487 issue: 5 year: 2005 end-page: 497 article-title: Adherence to medication publication-title: N Engl J Med – volume: 102 start-page: 493 issue: 2 year: 1992 end-page: 496 article-title: Factors influencing the eradication of with triple therapy publication-title: Gastroenterology – volume: 129 start-page: 1219.e1211 issue: 11 year: 2016 end-page: 1219.e1219 article-title: Online educational video improves bowel preparation and reduces the need for repeat colonoscopy within three years publication-title: Am J Med – volume: 2020 start-page: 8972473 year: 2020 article-title: Telephone‐based reeducation of drug administration for Eradication: a multicenter randomized controlled study publication-title: Gastroenterology Research and Practice – volume: 36 start-page: 2383 issue: 9 year: 2021 end-page: 2388 article-title: Clarithromycin versus furazolidone for naïve Helicobacter pylori infected patients in a high clarithromycin resistance area publication-title: J Gastroenterol Hepatol – volume: 43 start-page: 514 issue: 4 year: 2016 end-page: 533 article-title: Review article: the global emergence of antibiotic resistance publication-title: Aliment Pharmacol Ther – volume: 38 start-page: 1230 issue: 10 year: 2013 end-page: 1235 article-title: Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children‐a multicentre, open‐labelled study publication-title: Aliment Pharmacol Ther – volume: 2 start-page: 273 issue: 5 year: 2009 end-page: 279 article-title: Improving compliance with helicobacter pylori eradication therapy: when and how? publication-title: Therapeutic Advances in Gastroenterology – volume: 94 start-page: 811 issue: 3 year: 1999 end-page: 815 article-title: Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study publication-title: Am J Gastroenterol – volume: 41 start-page: 976 issue: 9 year: 2019 end-page: 980 article-title: Artificial intelligence in medical education publication-title: Med Teach – volume: 343 year: 2011 article-title: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials publication-title: BMJ – volume: 53 start-page: 163 issue: 2 year: 2002 end-page: 171 article-title: Management of Helicobacter pylori eradication–the influence of structured counselling and follow‐up publication-title: Br J Clin Pharmacol – volume: 21 start-page: 11179 issue: 39 year: 2015 end-page: 11184 article-title: Effects of daily telephone‐based re‐education before taking medicine on eradication: a prospective single‐center study from China publication-title: World J Gastroenterol – volume: 79 start-page: 358 issue: 4 year: 2016 end-page: 363 article-title: Mobile applications for mental health providers publication-title: Psychiatry – volume: 86 start-page: 27 issue: 2 year: 2014 end-page: 31 article-title: Patient compliance as one of the factors determining the efficiency of eradication therapy publication-title: Ter Arkh – volume: 345 start-page: 196 issue: 2 year: 2014 end-page: 202 article-title: Helicobacter pylori‐induced gastric inflammation and gastric cancer publication-title: Cancer Lett – volume: 23 issue: 2 year: 2018 article-title: Fifth Chinese National Consensus Report on the management of infection publication-title: Helicobacter – volume: 25 issue: 2 year: 2020 article-title: Application of a social media platform as a patient reminder in the treatment of publication-title: Helicobacter – volume: 153 start-page: 420 issue: 2 year: 2017 end-page: 429 article-title: Global Prevalence of Helicobacter pylori Infection: systematic Review and Meta‐Analysis publication-title: Gastroenterology – volume: 26 issue: 5 year: 2021 article-title: Application of WeChat platform in the management of patients infected with publication-title: Helicobacter – volume: 162 start-page: 32 issue: 1 year: 2022 end-page: 37 article-title: How we approach difficult to eradicate publication-title: Gastroenterology – ident: e_1_2_8_34_1 doi: 10.1001/jama.2012.3507 – ident: e_1_2_8_8_1 doi: 10.1136/gutjnl-2016-312288 – ident: e_1_2_8_19_1 doi: 10.11613/BM.2012.031 – ident: e_1_2_8_3_1 doi: 10.1186/s12929-018-0469-6 – volume: 86 start-page: 27 issue: 2 year: 2014 ident: e_1_2_8_14_1 article-title: Patient compliance as one of the factors determining the efficiency of eradication therapy publication-title: Ter Arkh – ident: e_1_2_8_15_1 doi: 10.1016/0016-5085(92)90095-G – ident: e_1_2_8_29_1 doi: 10.1056/NEJMra050100 – ident: e_1_2_8_31_1 doi: 10.1016/j.amjmed.2016.06.011 – ident: e_1_2_8_36_1 doi: 10.1259/bjr.20190389 – ident: e_1_2_8_33_1 doi: 10.1111/apt.12516 – ident: e_1_2_8_11_1 doi: 10.1111/apt.13497 – ident: e_1_2_8_32_1 doi: 10.1080/00332747.2016.1237753 – ident: e_1_2_8_24_1 doi: 10.1046/j.0306-5251.2001.01531.x – ident: e_1_2_8_2_1 doi: 10.1016/j.canlet.2013.08.016 – ident: e_1_2_8_12_1 doi: 10.1111/j.1365-2036.2011.04887.x – ident: e_1_2_8_23_1 doi: 10.1111/j.1572-0241.1999.00856.x – ident: e_1_2_8_26_1 doi: 10.3748/wjg.v21.i39.11179 – ident: e_1_2_8_28_1 doi: 10.1155/2020/8972473 – ident: e_1_2_8_7_1 doi: 10.1111/jgh.15468 – ident: e_1_2_8_21_1 doi: 10.1136/bmj.315.7109.629 – ident: e_1_2_8_9_1 doi: 10.1053/j.gastro.2021.10.048 – ident: e_1_2_8_13_1 doi: 10.1177/1756283X09337342 – ident: e_1_2_8_5_1 doi: 10.1111/apt.14561 – ident: e_1_2_8_30_1 doi: 10.1080/00365521.2017.1413132 – ident: e_1_2_8_10_1 doi: 10.1053/j.gastro.2019.04.011 – ident: e_1_2_8_35_1 doi: 10.1080/0142159X.2019.1595557 – ident: e_1_2_8_16_1 doi: 10.2165/00003495-199754060-00002 – ident: e_1_2_8_27_1 doi: 10.1111/hel.12569 – ident: e_1_2_8_4_1 doi: 10.1053/j.gastro.2017.04.022 – ident: e_1_2_8_22_1 doi: 10.2307/2533446 – ident: e_1_2_8_25_1 doi: 10.1111/hel.12682 – ident: e_1_2_8_17_1 doi: 10.1111/hel.12832 – ident: e_1_2_8_18_1 doi: 10.1016/j.jclinepi.2009.06.005 – ident: e_1_2_8_20_1 doi: 10.1136/bmj.d5928 – ident: e_1_2_8_6_1 doi: 10.1111/hel.12475 |
SSID | ssj0005349 |
Score | 2.4532037 |
SecondaryResourceType | review_article |
Snippet | Background
Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor... Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and... BackgroundHelicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor... Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e12880 |
SubjectTerms | Anti-Bacterial Agents - pharmacology Clinical trials Confidence intervals Diarrhea Drug Therapy, Combination Education enhanced patient education Eradication eradication rate Gastric cancer Helicobacter Infections - diagnosis Helicobacter pylori Humans Meta-analysis Nausea Patient education Patient satisfaction Patients Remission Side effects Stomach Neoplasms - drug therapy Subgroups systematic review Taste disorders |
Title | Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta‐analysis |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhel.12880 https://www.ncbi.nlm.nih.gov/pubmed/35150600 https://www.proquest.com/docview/2637588622 https://www.proquest.com/docview/2628299715 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VlUBceJTXloIGxKGXrDZ2XoZThVqtEOWAqNQDUmQ7YxVRshW7e2hP_AR-I7-EGedRykNC3CLFcRJ7xvPNePwNwHMzc2WTUZFoa7Iks02ZGO2rJGRBpV6zQSCJdxy-LeZH2evj_HgDXg5nYTp-iDHgJpoR12tRcOuWPyn5CZ1OeXGtxF-XXC0BRO8uqaNyHaFvyhAjkQrfPauQZPGMT161Rb8BzKt4NRqcg1vwYfjULs_k03S9clN_8QuL43_-y2242QNR3Osk5w5sULsF17rSlOdbcP2w33S_Cxcdw_ESFwGpPYkpA0hDYggy6sWenXWJEtZFxpTI5oxlzEUuaDyTqMBHHBK_2he4h5cU0tgdn0HbNviZVvb712-2p0q5B0cH--9fzZO-ZEPihVUmMZnThbW-DDp4BpOKXEl5KBVpmnkqvEkp837miNcZRk6krJsZFciGqshVru_DZrto6SFg2rgg5GFVyLhXY51qlKly41h6AqVmArvD5NW-5zOXshqn9eDX8KjWcVQn8GxsetaRePyp0c4gAXWvx8taFZodKvb61ASejrdZA2Vbxba0WEsb2Y02ZZpP4EEnOeNbdB4ZHLnz3Tj_f399Pd9_Ey-2_73pI7ih5DRGTCTagc3VlzU9Zoy0ck-iMvwAzbUOUw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRTwuPAqFLQUGxKGXrDZ2Xq64VNBqgd0eUCv1giLbGauIkq3Y3QM99SfwG_klHTuPUh4S4hYpjp04M55vxuNvAF6qkcmrhLJIapVEia7ySElbRC5xIraSDQL5eMd0PxsfJu-O0qMVeNWdhWn4IfqAm9eMsF57BfcB6Z-0_JhOhry6FuywX_MVvT1z_psPl-RRqQzgN2aQEfka3y2vkM_j6R-9ao1-g5hXEWswOXt34GP3sk2myefhcmGG9uwXHsf__Zq7cLvForjTCM89WKF6Da431Sm_rcGNabvvfh_OGpLjOc4cUn0csgaQutwQZOCLLUHrHH1kFxlWIls0FjMT6KDx1AcGPmGX-1Vv4w5eskhjc4IGdV3hF1roH-ffdcuW8gAO93YPXo-jtmpDZD2xTKQSIzOtbe6ks4wnBZmcUpcLkjSylFkVU2LtyBAvNQyeSGgzUsKRdkWWilSuw2o9q-kRYFwZ5_nDCpdwr0obUQlVpMqwADmK1QC2ur9X2pbS3FfWOCk714ZntQyzOoAXfdPThsfjT402OxEoW1WelyKT7FOx4ycG8Ly_zUrod1Z0TbOlb-M3pFUepwN42IhOP4pMA4kjd74VBODvw5fj3Um42Pj3ps_g5vhgOiknb_ffP4Zbwh_OCHlFm7C6-LqkJwyZFuZp0IwLnwQSbw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5Vrai4UFpe25ZiEIdeskps52E4VbSrBdoKISr1gBTZzlhFlOyqu3ugJ35CfyO_hLHzKOUhIW6R4jiJPeP5Zjz-BuC5ik1eScwioZWMpK7ySAlbRE46nlhBBgF9vOPoOBufyDen6ekSvOzOwjT8EH3AzWtGWK-9gk8r95OSn-H5kBbXgvz1FZnFytdt2H9_zR2VioB9E8IYkS_x3dIK-TSe_tGbxug3hHkTsAaLM1qDj923Nokmn4eLuRnay19oHP_zZ-7CnRaJsr1GdNZhCesNuNXUpvy6AatH7a77PbhsKI5nbOIY1mchZ4BhlxnCCPaylp51xnxclxGoZGTPSMhMIINmUx8W-MS6zK_6Bdtj1xzSrDk_w3RdsS8419-_XemWK-U-nIwOPrwaR23Nhsh6WplISSMyrW3uhLOEJjmaHFOXcxQYW8ysSlBaGxukhYagE3JtYsUdaldkKU_FA1iuJzU-ApZUxnn2sMJJ6lVpwyuuilQZEh-HiRrAbjd5pW0JzX1djfOyc2xoVMswqgN41jedNiwef2q03UlA2SryrOSZII-K3D4-gKf9bVJBv6-ia5wsfBu_Ha3yJB3Aw0Zy-reINFA4Uue7Yf7__vpyfHAYLjb_vekTWH23PyoPXx-_3YLb3J_MCElF27A8v1jgY8JLc7MT9OIHYg0RHg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+enhanced+education+for+patients+with+the+Helicobacter+pylori+infection%3A+A+systematic+review+and+meta-analysis&rft.jtitle=Helicobacter+%28Cambridge%2C+Mass.%29&rft.au=Zha%2C+Jing&rft.au=Li%2C+Yue-Yue&rft.au=Qu%2C+Jun-Yan&rft.au=Yang%2C+Xiao-Xiao&rft.date=2022-04-01&rft.issn=1523-5378&rft.eissn=1523-5378&rft.volume=27&rft.issue=2&rft.spage=e12880&rft_id=info:doi/10.1111%2Fhel.12880&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1083-4389&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1083-4389&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1083-4389&client=summon |